Lake Zurich-based Fresenius Kabi Tuesday announced the immediate availability of Romidepsin for Injection in the United States, the newest addition to the company’s broad portfolio of injectable cancer medicines.
Related posts
-
Weppner’s 3 TD night helps Geneva snap long losing skid to Batavia
Geneva wide receiver Finnegan Weppner had three touchdowns in the second half to lead the Vikings... -
Fremd QB’s historic night leads Vikings over Barrington
Fremd southpaw QB Danny O'Brien threw for a school-record 395 yards, breaking the record of Chicago... -
One year later: Specter of Oct. 7 hovers over High Holiday celebrations
Suburban Jews reflect on the anniversary of the Oct. 7 Hamas attacks in Israel while observing...